Latest filing published 29 Jan 2007 for PDL BIOPHARMA, INC., €11k.
Insider track record
No signal scores available.
Peter H. Calcott: trading record in brief
This profile gathers the share dealings of Peter H. Calcott in PDL Biopharma, Inc. We count 3 filings; the first trade dates from 5 July 2006 and the latest from 5 January 2007.
Sales make up the whole of the open-market record (3 sales, €27k). So far in 2007, the count stands at no purchases and 1 sale.
Most recently, on 29 January 2007, the filings show an open-market sale worth €11k in PDL Biopharma, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Peter H. Calcott
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 670 shares@ US$20.47Common StockSEC:0001140361-07-001981:0
- 625 shares@ US$20.34Common StockSEC:0001140361-06-014428:0
- 439 shares@ US$18.44Common StockSEC:0001140361-06-010080:0
3 of 3 declarations
